Pendal Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $491K | Sell |
10,612
-217
| -2% | -$10K | ﹤0.01% | 375 |
|
|
2022
Q3 | $419K | Sell |
10,829
-653
| -6% | -$25.3K | ﹤0.01% | 361 |
|
|
2022
Q2 | $428K | Sell |
11,482
-927
| -7% | -$34.6K | ﹤0.01% | 371 |
|
|
2022
Q1 | $550K | Sell |
12,409
-48,640
| -80% | -$2.16M | ﹤0.01% | 394 |
|
|
2021
Q4 | $2.59M | Buy |
61,049
+42,782
| +234% | +$1.82M | 0.02% | 212 |
|
|
2021
Q3 | $792K | Buy |
18,267
+4,916
| +37% | +$213K | 0.01% | 352 |
|
|
2021
Q2 | $571K | Sell |
13,351
-268
| -2% | -$11.5K | 0.01% | 401 |
|
|
2021
Q1 | $526K | Buy |
13,619
+2,970
| +28% | +$115K | 0.01% | 402 |
|
|
2020
Q4 | $383K | Sell |
10,649
-1,190
| -10% | -$42.8K | ﹤0.01% | 404 |
|
|
2020
Q3 | $452K | Sell |
11,839
-7,224
| -38% | -$276K | 0.01% | 327 |
|
|
2020
Q2 | $669K | Buy |
19,063
+6,625
| +53% | +$232K | 0.01% | 280 |
|
|
2020
Q1 | $406K | Buy |
12,438
+1,463
| +13% | +$47.7K | 0.01% | 287 |
|
|
2019
Q4 | $496K | Sell |
10,975
-89
| -0.8% | -$4.03K | 0.01% | 312 |
|
|
2019
Q3 | $450K | Sell |
11,064
-881
| -7% | -$35.8K | 0.01% | 363 |
|
|
2019
Q2 | $513K | Buy |
11,945
+940
| +9% | +$40.4K | 0.01% | 347 |
|
|
2019
Q1 | $422K | Buy |
11,005
+3,693
| +51% | +$142K | 0.01% | 371 |
|
|
2018
Q4 | $258K | Buy |
+7,312
| New | +$258K | ﹤0.01% | 371 |
|